Unknown

Dataset Information

0

Isodicentric Philadelphia chromosome: an uncommon chromosomal abnormality in the chronic phase of chronic myeloid leukemia (CML).

ABSTRACT: An isodicentric Philadelphia chromosome is an uncommon finding previously described as a secondary chromosomal abnormality in accelerated- or blast-phase of chronic myeloid leukemia (CML) with resistance to imatinib mesylate or dasatinib. Here, we present a case with idic(Ph) chromosome identified at initial diagnosis in a patient with chronic-phase CML.

SUBMITTER: Loo E 

PROVIDER: S-EPMC4706395 | biostudies-other | 2016 Jan

REPOSITORIES: biostudies-other

Json Xml

Similar Datasets

Unknown Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome-positive chronic myeloid leukemia.
| S-EPMC6923664 | biostudies-literature
Unknown A phase 4 study of nilotinib in Korean patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTKorea.
| S-EPMC5943463 | biostudies-literature
Unknown Cytogenetic and Molecular Analyses of Philadelphia Chromosome Variants in CML (chronic myeloid leukemia) Patients from Sindh using Karyotyping and RT-PCR.
| S-EPMC4590377 | biostudies-literature
Unknown Clonal chromosomal abnormalities appearing in Philadelphia chromosome-negative metaphases during CML treatment.
| S-EPMC5680612 | biostudies-literature
Unknown Phase II trial of hyper CVAD and dasatinib in patients with relapsed Philadelphia chromosome positive acute lymphoblastic leukemia or blast phase chronic myeloid leukemia.
| S-EPMC4196860 | biostudies-literature
Unknown Nilotinib first-line therapy in patients with Philadelphia chromosome-negative/BCR-ABL-positive chronic myeloid leukemia in chronic phase: ENEST1st sub-analysis.
| S-EPMC5486575 | biostudies-literature
Unknown Impact of additional chromosomal aberrations and BCR-ABL kinase domain mutations on the response to nilotinib in Philadelphia chromosome-positive chronic myeloid leukemia.
| S-EPMC2857187 | biostudies-literature
Unknown Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome-positive chronic myeloid leukemia patients with resistance or intolerance to imatinib.
| S-EPMC4916618 | biostudies-literature
Unknown Targeting Abnormal Hematopoietic Stem Cells in Chronic Myeloid Leukemia and Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms.
| S-EPMC7827471 | biostudies-literature
Unknown Practical management of toxicities associated with bosutinib in patients with Philadelphia chromosome-positive chronic myeloid leukemia.
| S-EPMC5888919 | biostudies-literature